Egg-freezing has risen in lockdown, but it’s not the cure-all it’s cracked up to be
By Katie Strick and Lucy Holden,
Evening Standard
| 11. 10. 2020
Alice Mann wishes she’d known the odds from the start. The marketing consultant was 36, single and heartbroken after the end of a two-year relationship when she read a magazine article about freezing her eggs, a process which allows women to preserve them to use in IVF at a later date. She knew she wanted children, so spending £14,000 on the procedure felt like a worthwhile (albeit expensive) insurance policy, a way of buying some “breathing space” in the hope that she’d meet someone new.
It came as a shock, then, still single at 40 and mid-way through an attempt to fertilise her frozen eggs with donor sperm, when she received a call from the clinic. Of the seven eggs they’d defrosted, only two fertilised and both were abnormal, so there were no embryos left.
“I was utterly floored by the news and felt angry; resentful at the universe,” says Mann, now 43 and undergoing IVF with a new partner. “Tears welled in my eyes because I thought the worst-case scenario would be one slightly crappy...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...